Kling-Petersen T, Ljung E, Svensson K
Department of Pharmacology, University of Göteborg, Sweden.
J Neural Transm Gen Sect. 1995;102(3):209-20. doi: 10.1007/BF01281155.
Compounds showing an in vitro binding preference for the dopamine D3 vs. D2 receptors were tested for effects on locomotor activity after local application in the nucleus accumbens (N Acc) and the ventral tegmental area (VTA) of the rat brain. R-(+)-7-OH-DPAT, a dopamine D3 preferring agonist, inhibited spontaneous locomotor activity over a wide dose range after injection into the N Acc. A decrease in activity over a wide dose range was also seen after local application into the VTA of both R-(+)-7-OH-DPAT and the dopamine D2 preferring agonist (+)-3-PPP. Furthermore, (+)-3-PPP produced a dose dependent increase in activity after local application into the N Acc. The putative D3 antagonist, U99194A, with a 30 fold preference for the dopamine D3 vs. D2 receptor, produced an increase in activity when injected into the N Acc. A similar pattern were seen after infusion into the lateral ventricle. Local application into the VTA did, however, not produce any significant effects. The present results support the hypothesis that dopamine D3 receptors (in contrast to the D2 receptors) are mainly postsynaptically located where they display an inhibitory action on locomotor activity.
对那些在体外对多巴胺D3受体而非D2受体表现出结合偏好的化合物,在大鼠脑内伏隔核(N Acc)和腹侧被盖区(VTA)局部给药后,测试其对运动活性的影响。R-(+)-7-羟基-二丙基氨基四氢萘(R-(+)-7-OH-DPAT),一种对多巴胺D3受体有偏好的激动剂,注入伏隔核后,在很宽的剂量范围内抑制自发运动活性。在R-(+)-7-OH-DPAT和对多巴胺D2受体有偏好的激动剂(+)-3-苯基-1-丙基哌嗪((+)-3-PPP)局部注入腹侧被盖区后,在很宽的剂量范围内也观察到活性降低。此外,(+)-3-PPP局部注入伏隔核后产生剂量依赖性的活性增加。公认的D3拮抗剂U99194A,对多巴胺D3受体的偏好是对D2受体的30倍,注入伏隔核时产生活性增加。注入侧脑室后也观察到类似模式。然而,局部注入腹侧被盖区并未产生任何显著影响。目前的结果支持以下假设:多巴胺D3受体(与D2受体相反)主要位于突触后,对运动活性发挥抑制作用。